|About||Users 5||Reviews||Exhibitors||Photos||Speakers||Travel Deals|
"Dedicated to Realizing the Commercial Potential of Gene Therapies"
Gene Therapy for Rare Disorders focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Incorporating insights from Spark, FDA, Bluebird Bio, Pfizer and GSK, this unique conference delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.
Timings09:00 AM-06:00 PM (expected)
Entry FeesCheck Official Website
10 - 50 Exhibitors Estimated Count
Category & TypeConference
Medical & Pharma
Editions30 Mar - 02 Apr 2020 Interested
26 - 28 Mar 2019 3rd Edition
30 Apr - 02 May 2018View More
Official LinksWebsite Contacts
Claim this event
OrganizerSend Stall Book Request